The new QIAstat-Dx BCID GN Plus AMR Panel identifies 13 gram-negative bacterial pathogen targets and 18 antimicrobial ...
Through the reseller agreement, customers will be able to purchase Evosep Eno directly through Thermo Fisher Scientific, ...
Barbara Krebs-Pohl, Anne Prener, and Camilla Soenderby, were appointed as independent members of the Company’s Board of ...
Lift Therapeutics (‘Lift’ or ‘the Company’) today announced the appointment of Eva Ehrnrooth, MD, PhD, as Executive Head of ...
The XVIVO heart technology is not commercially available in the US. GOTHENBURG, SE / ACCESS Newswire / / XVIVO Perfusion AB ...
(Nasdaq: MIRM), a leading rare disease company, today announced that it will host an investor call on Monday, September 28, ...
FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases HONG KONG and SHANGHAI and ...
For further information: Dr. Madi R. Madiyalakan, CEO, Quest PharmaTech Inc. Tel: (780) 448-1400, E-mail: ...
Stem cell therapies vary widely yet many physicians still treat them as interchangeable. A more credible model requires ...
The recent FDA approval of Fayuvi for a rare, childhood neurodegenerative disease was “particularly special” for Ultragenyx ...
• ROTH Healthcare Opportunities Conference (New York, September 29, 2026): BJ Sullivan, Dov Goldstein, MD, CFO, and Alexis ...
PEDS, the first and largest Phase 3 study specifically designed to evaluate pediatric patients with severe alopecia areata ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results